23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
By letter dated August 2, 2024, a Special Committee of the Board of Directors of 23andMe rejected that offer, noting that it "provide[d] no premium to the closing price per share on ... holder of ...
The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...
On Friday, 23andMe Holding Co. (ME) stock saw a modest uptick, ending the day at $0.34 which represents a slight increase of $0.01 or 3.03% from the prior close of $0.33. The stock opened at $0.33 and ...
23andMe went public in June 2021 on the NASDAQ, riding the special purpose acquisition company (SPAC) wave – raising $592 ...
When 23andMe went public in 2021 via a SPAC merger, its $10 per share stock price soon rose by more than 20%. The company has not seen such highs since. 23andMe has struggled with its vision ...
On Friday, 23andMe Holding Co. (ME) stock saw a decline, ending the day at $0.3 which represents a decrease of $-0.01 or -3.23% from the prior close of $0.31. The stock opened at $0.31 and touched a ...
Citi analyst David Lebovitz maintained a Hold rating on 23andMe Holding (ME – Research Report) yesterday and set a price target of $0.42.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback